Pietro D. Ragonesi

Effects of Telmisartan Compared with Eprosartan on Blood Pressure Control, Glucose Metabolism and Lipid Profile in Hypertensive, Type 2 Diabetic Patients: a Randomized, Double-Blind, Placebo-Controlled 12-Month Study

Giuseppe Derosa, Pietro D. Ragonesi, Amedeo Mugellini et al. · Hypertension Research · 2004 · 167 citations · Full text

Metabolic effects of pioglitazone and rosiglitazone in patients with diabetes and metabolic syndrome treated with glimepiride: A twelve-month, multicenter, double-blind, randomized, controlled, parallel-group trial

Giuseppe Derosa, Arrigo F.G. Cicero, A. Gaddi et al. · Clinical Therapeutics · 2004 · 130 citations

Obesity, Metabolic Syndrome, Diabetes Management +8

Effects of sitagliptin or metformin added to pioglitazone monotherapy in poorly controlled type 2 diabetes mellitus patients

Giuseppe Derosa, Pamela Maffioli, Sibilla Salvadeo et al. · Metabolism · 2009 · 114 citations

Metabolic Syndrome, Diabetes Management, Medicine +7

Telmisartan and Irbesartan Therapy in Type 2 Diabetic Patients Treated with Rosiglitazone: Effects on Insulin-Resistance, Leptin and Tumor Necrosis Factor-.ALPHA.

Giuseppe Derosa, Arrigo F.G. Cicero, Angela D’Angelo et al. · Hypertension Research · 2006 · 79 citations · Full text

A comparison of the effects of pioglitazone and rosiglitazone combined with glimepiride on prothrombotic state in type 2 diabetic patients with the metabolic syndrome

Giuseppe Derosa, Arrigo F.G. Cicero, A. Gaddi et al. · Diabetes Research and Clinical Practice · 2004 · 73 citations

Obesity, Metabolic Syndrome, Diabetes Management +8